BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 7837164)

  • 1. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.
    Gordon P; Khamashta MA; Rosenthal E; Simpson JM; Sharland G; Brucato A; Franceschini F; De Bosschere K; Meheus L; Meroni PL; Hughes GR; Buyon J
    J Rheumatol; 2004 Dec; 31(12):2480-7. PubMed ID: 15570655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.
    Tonello M; Ruffatti A; Marson P; Tison T; Marozio L; Hoxha A; De Silvestro G; Punzi L
    Transfusion; 2015 Jul; 55(7):1782-6. PubMed ID: 25825254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
    Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
    Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
    Costedoat-Chalumeau N; Amoura Z; Lupoglazoff JM; Huong DL; Denjoy I; Vauthier D; Sebbouh D; Fain O; Georgin-Lavialle S; Ghillani P; Musset L; Wechsler B; Duhaut P; Piette JC
    Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring.
    Stea EA; Routsias JG; Clancy RM; Buyon JP; Moutsopoulos HM; Tzioufas AG
    Arthritis Rheum; 2006 Jul; 54(7):2228-34. PubMed ID: 16802359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block.
    Horsfall AC; Li JM; Maini RN
    J Autoimmun; 1996 Aug; 9(4):561-8. PubMed ID: 8864833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.